An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12. The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children. Which of the following is the investigator's most appropriate course of action?

Quesiton : An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12. The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children. Which of the following is the investigator's most appropriate course of action?

Answer: Submit the research protocol to the IRB for review and submit an IND application to the FDA before conducting the research

An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12. The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children. Which of the following is the investigator's most appropriate course of action? An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12 . The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children . An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12 . The drug sponsor hopes that the information from the research can be used to change the labeling for use of the drug in younger children . Mon Mar 05 2012 · Q.92) An investigator proposes to study a marketed product sold to treat high blood pressure in individuals over age 12 using a liquid formulation for children under age 12 . The drug sponsor hopes the information from the research can be used to change the labeling for use of the drug in children . Wed Jul 11 2018 00:00:00 GMT+0530 (IST) · A new study published in Nature Medicine found that a drug used to treat high blood pressure could help patients ... Patients can often face risks over overcorrecting their blood sugar levels ... Wed Jul 11 2018 00:00:00 GMT+0530 (IST) · A new study published in Nature Medicine found that a drug used to treat high blood pressure could help patients with type 1 diabetes stabilise blood sugar levels. Verapamil a …